In the temporal cortex from AD patients, the reduced mRNA expressions of astrocytic end-feet water channel aquaporin 4 (AQP4) and activated astrocyte marker glial fibrillary acidic protein (GFAP) were observed in association with the severity of CAA pathology [126]. The gene discussed is GFAP; the disease is Alzheimer disease.